Sort
11,323 grants matching “glioblastoma”
Synergistic microglial activation and tumor cell killing for improved GBM response
$402,500Vidyalakshmi Chandramohan · Duke University · R01 · FY2022 · NS
Reprograming Macrophages and Targeting Glioma Stem Cells in Glioblastoma
$402,500Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · NS
Sema3C Signaling as an Alternative Activator of Canonical Wnt Signaling in Glioblastoma
$402,500Jennifer S Yu · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · NS
Sema3C Signaling as an Alternative Activator of Canonical Wnt Signaling in Glioblastoma
$402,500Jennifer S Yu · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · NS
Synergistic microglial activation and tumor cell killing for improved GBM response
$402,500Vidyalakshmi Chandramohan · Duke University · R01 · FY2023 · NS
Reprograming Macrophages and Targeting Glioma Stem Cells in Glioblastoma
$402,500Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · NS
Synergistic microglial activation and tumor cell killing for improved GBM response
$402,500Vidyalakshmi Chandramohan · Duke University · R01 · FY2025 · NS
Innate Antiviral Signals for Cancer Immunotherapy
$402,500Matthias Gromeier · Duke University · R01 · FY2025 · NS
Mechanism and therapeutic potential of microglia regulation in glioblastoma
$402,500Peiwen Chen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · NS
Synergistic microglial activation and tumor cell killing for improved GBM response
$402,500Vidyalakshmi Chandramohan · Duke University · R01 · FY2021 · NS
Gene Edited and Engineered Tumor Cell Therapeutics for Cancer
$402,467Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2024 · NS
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy
$402,460Robert M Prins · University Of California Los Angeles · R01 · FY2023 · CA
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy
$402,457Robert M Prins · University Of California Los Angeles · R01 · FY2022 · CA
Evaluating the role of SPAK and OSR1 kinases in glioblastoma chemotherapy resistance
$402,401Paula V Schiapparelli · Mayo Clinic Jacksonville · R21 · FY2024 · CA
Microfluidics Array Based Sorting, Isolation, and RNA Analysis in Single Extracellular V csicles
$402,348Eduardo Reategui · Ohio State University · UG3 · FY2019 · TR
Metabolism Informs Intertumoral & Intratumoral Heterogeneity
$402,301Jeremy N Rich · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · NS
Molecular Imaging Markers for Glutaminolysis in Breast Cancer
$402,259David A Mankoff · University Of Pennsylvania · R01 · FY2020 · CA
Molecular Imaging Markers for Glutaminolysis in Breast Cancer
$402,259David A Mankoff · University Of Pennsylvania · R01 · FY2021 · CA
Engineering the Brain Immune System for Tumor Therapy
$402,188Maria G Castro · Cedars-Sinai Medical Center · R01 · FY2010 · NS
Controlled Release of Macromolecules
$402,150Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2010 · EB
Project 2: Molecular and Clinical Inputs Affecting Optimization of Glioma Therapy
$402,149Eric C Holland · Dana-Farber Cancer Inst · U54 · FY2018 · CA
RNA-binding Factors Implicated in Neurogenesis, Alzheimer's Disease, and other Neurodegenerative Pathologies
$402,131Myriam Gorospe · National Institute On Aging · ZIA · FY2022 · AG
Targeting BCAT1 and branched-chain amino acid metabolism for the detection and prevention of SCLC
$402,073Kwon-Sik Park · University Of Virginia · U01 · FY2022 · CA
Novel functions of Pyruvate kinase M2 in DNA double-strand break repair
$401,992Fen Xia · Ohio State University · R01 · FY2014 · CA
Regulation and Function of Ascl1 (Mash1) in Neural Development
$401,802Jane E Johnson · Ut Southwestern Medical Center · R01 · FY2010 · NS